FDA: Serious Liver Injury Being Observed in Patients Without Cirrhosis Taking Ocaliva (Obeticholic Acid) to Treat Primary Biliary Cholangitis
FDA:在無肝硬化的患者中觀察到服用Ocaliva(奧貝膽酸)治療原發性膽汁性膽管炎的嚴重肝損傷
FDA: Serious Liver Injury Being Observed in Patients Without Cirrhosis Taking Ocaliva (Obeticholic Acid) to Treat Primary Biliary Cholangitis
FDA:在無肝硬化的患者中觀察到服用Ocaliva(奧貝膽酸)治療原發性膽汁性膽管炎的嚴重肝損傷
使用瀏覽器的分享功能,分享給你的好友吧